Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy

被引：0
|
作者：
Larru, Beatriz [1 ]
Resino, Salvador [1 ,2 ]
Bellon, Jose M. [1 ]
Isabel de Jose Gomez, M. [3 ]
Fortuna, Claudia [4 ]
Munoz-Fernandez, M. Angeles [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid 28007, Spain
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
[3] Hosp Univ La Paz, Serv Inmunopediat, Madrid, Spain
[4] Hosp San Joan de Deu, Serv Inmunopediat, Barcelona, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2008年 / 26卷 / 07期
关键词：
HIV; HCV; LPV/r; HAART; children;
D O I：
10.1157/13125640
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
INTRODUCTION. There are few studies investigating the effect of HCV coinfection on HIV-related disease among children. METHODS. We studied 5 HIV/HCV coinfected children receiving an LPV/r-containing HAART regimen. Their evolution was compared with a control group of 72 HIV-infected children. RESULTS. All 5 HIV/HCV-coinfected children achieved sustained immune recovery during the study. Moreover, they showed better viral suppression than the control group. None of the 5 HIV/HCV-coinfected children experienced any adverse effects with the use of LPV/r. CONCLUSION. HIV/HCV coinfection does not reduce the benefits obtained from HAART.
引用
收藏
页码：426 / 429
页数：4
相关论文
共 50 条
  • [31] Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy
    Chadwick, Ellen G.
    Yogev, Ram
    Alvero, Carmelita G.
    Hughes, Michael D.
    Hazra, Rohan
    Pinto, Jorge A.
    Robbins, Brian L.
    Heckman, Barbara E.
    Palumbo, Paul E.
    Capparelli, Edmund V.
    AIDS, 2011, 25 (05) : 643 - 649
  • [32] Risk of liver toxicity in HIV/HCV coinfected patients with advanced chronic liver disease receiving nevirapine (Viramune®) or lopinavir/ritonavir (Kaletra®)
    Dragovic, G.
    Jevtovic, D. J.
    DRUG SAFETY, 2006, 29 (10) : 985 - 985
  • [33] Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults
    Achenbach, Chad J.
    Darin, Kristin M.
    Murphy, Robert L.
    Katlama, Christine
    FUTURE VIROLOGY, 2011, 6 (02) : 157 - 177
  • [34] Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy
    Ragazini, Conrado S.
    Bahamondes, Maria Valeria
    Rocha Prandini, Tatiana R.
    Brito, Milena Bastos
    Amaral, Eliana
    Bahamondes, Luis
    Duarte, Geraldo
    Quintana, Silvana Maria
    Ferriani, Rui Alberto
    Vieira, Carolina Sales
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (04): : 285 - 289
  • [35] Long-term immunologic outcome in HAART-experienced subjects receiving lopinavir/ritonavir
    Bongiovanni, Marco
    Bini, Teresa
    Casana, Maddalena
    Cicconi, Paola
    Tordato, Federica
    Monforte, Antonella D'Arminio
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (11) : 1099 - 1105
  • [36] Efficacy and safety of lopinavir/ritonavir-based antiretroviral therapy in HIV-1-infected subjects with advanced disease: a systematic review and meta-analysis
    van Wyk, Jean
    Fredrick, Linda M.
    Dorr, Pat
    Madihlaba, Tshepiso
    FUTURE VIROLOGY, 2015, 10 (08) : 949 - 959
  • [37] Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy
    Achan, Jane
    Kakuru, Abel
    Ikilezi, Gloria
    Mwangwa, Florence
    Plenty, Albert
    Charlebois, Edwin
    Young, Sera
    Havlir, Diane
    Kamya, Moses
    Ruel, Theodore
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1329 - 1332
  • [38] The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
    Lee, Silvia
    Laiman, Alfred
    French, Martyn A.
    Flexman, James
    Watson, Mark W.
    Price, Patricia
    CLINICAL IMMUNOLOGY, 2017, 179 : 54 - 63
  • [39] Mortality and Long-term Virologic Outcomes in Children and Infants Treated With Lopinavir/Ritonavir
    Estripeaut, Dora
    Mosser, Jon
    Doherty, Meg
    Acosta, William
    Shah, Harita
    Castano, Elizabeth
    Luciani, Kathia
    Pascale, Juan Miguel
    Bollinger, Robert C.
    Page, Kathleen R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (12) : E466 - E472
  • [40] Complications of long-term antiretroviral therapy in HIV-infected children
    Prendergast, Andrew J.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (04) : 245 - 246
12345